Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
基于因果人工智能的临床和放射组学分析用于优化早期非小细胞肺癌联合免疫疗法和立体定向消融放疗(SABR)的患者选择:II期I-SABR试验的二次分析
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013074
Saad, Maliazurina B; Showkatian, Eman; Verma, Vivek; Al-Tashi, Qasem; Aminu, Muhammad; Xu, Xinyan; Qayati Mohamed, Muhamed; Salehjahromi, Morteza; Sujit, Sheeba J; Kitsel, Yuliya; Lin, Steven H MD,; Liao, Zhongxing; Gandhi, Saumil; Qian, David; Jaffray, David; Chung, Caroline; Vokes, Natalie I; Zhang, Jianjun; Lee, J Jack; Heymach, John V; Wu, Jia; Chang, Joe Y